Table 3 Pain, exocrine and endocrine functions at the last follow-up
From: Risk of pancreatic cancer in patients undergoing surgery for chronic pancreatitis
Characteristics | Cancer group (n = 12) | Non-cancer group (n = 638) | P |
|---|---|---|---|
Postoperative abdominal pain | 6 (50%) | 184(28.8%) | 0.110 |
De novo pain | 0 (0%) of 1 patient | 4 (7.4%) of 54 patients | 1.0 |
Worsening pain | 1 (9.1%) of 11 patients | 11 (1.9%) of 584 patients | 0.202 |
Total postoperative endocrine insufficiency | 8 (66.7%) | 266 (41.7%) | 0.083 |
De novo endocrine insufficiency | 4 (50.0%) of 8 patients | 22 (5.6%) of 394 patients | 0.001 |
Total postoperative exocrine insufficiency | 3 (25%) | 151 (23.7%) | 0.914 |
De novo exocrine insufficiency | 1 (10.0%) of 10 patients | 34 (6.5%) of 521 patients | 0.497 |